Photosensitivity Disorders Clinical Trial
Official title:
Comparison of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head
Topical treatment of mild to moderate actinic keratosis located on the face and head with
Solaraze® is known to be a safe and efficient treatment option. However, it is unclear if an
expansion of the treatment period to 6 months will increase the rate of complete responses.
Therefore the investigators will evaluate the efficacy and safety of the treatment of
actinic keratosis with Solaraze® applied twice daily to the face and head over 3 or 6 months
of treatment.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01776983 -
Skin Aging in Renal Transplant Patients
|
Phase 4 | |
| Completed |
NCT01491620 -
Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte
|
N/A | |
| Recruiting |
NCT02904564 -
Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation
|
Phase 4 |